Late-Breaking Data: Super Responders With Delgocitinib for CHE
April Armstrong, MD, MPH, FAAD, discusses her late-breaking presentation at AAD on the treatment response in patients with moderate to severe chronic CHE treated with delgocitinib.
April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report
Armstrong shared insights on the recently released NPF psoriasis health indicator report including pearls on national health data and unmet needs in public health campaigns.
Top 5 Articles of the Week: April 13-18
Dermatology Times' Sunday Crossword: April 20, 2025
The Weekly Roundup: April 14-18
The Rx Recap: April 13-19